Immunosequencing: applications of immune repertoire deep sequencing
H Robins - Current opinion in immunology, 2013 - Elsevier
Highlights•New technology to profile the adaptive immune system with high-throughput
sequencing of adaptive immune receptors.•Ability to follow the dynamics of an adaptive …
sequencing of adaptive immune receptors.•Ability to follow the dynamics of an adaptive …
Getting personal with neoantigen-based therapeutic cancer vaccines
N Hacohen, EF Fritsch, TA Carter, ES Lander… - Cancer immunology …, 2013 - AACR
Despite years of preclinical efforts and hundreds of clinical studies, therapeutic cancer
vaccines with the routine ability to limit or eliminate tumor growth in humans have been …
vaccines with the routine ability to limit or eliminate tumor growth in humans have been …
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients
PY Yew, H Alachkar, R Yamaguchi, K Kiyotani… - Bone marrow …, 2015 - nature.com
Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment
options for patients with hematologic malignancies. Although GVHD mediated by the donor's …
options for patients with hematologic malignancies. Although GVHD mediated by the donor's …
60 years young: the evolving role of allogeneic hematopoietic stem cell transplantation in cancer immunotherapy
The year 2020 marked the 30th anniversary of the Nobel Prize in Medicine awarded to E.
Donnall Thomas for the development of allogeneic hematopoietic stem cell transplantation …
Donnall Thomas for the development of allogeneic hematopoietic stem cell transplantation …
New challenges, new opportunities: Next generation sequencing and its place in the advancement of HLA typing
V Bravo-Egana, H Sanders, N Chitnis - Human Immunology, 2021 - Elsevier
Abstract The Human Leukocyte Antigen (HLA) system has a critical role in
immunorecognition, transplantation, and disease association. Early typing techniques …
immunorecognition, transplantation, and disease association. Early typing techniques …
Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies
G Lucchini, MA Perales, P Veys - Cytotherapy, 2015 - Elsevier
Umbilical cord blood (UCB) is now widely used as an alternative hematopoietic stem cell
source for patients lacking closely matched related or unrelated adult donors. UCB …
source for patients lacking closely matched related or unrelated adult donors. UCB …
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection
Background T-cell-mediated rejection (TCMR) remains a major cause of kidney allograft
failure. The characterization of T-cell repertoire in different immunological disorders has …
failure. The characterization of T-cell repertoire in different immunological disorders has …
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-
prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is …
prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is …
Diagnostic applications of next generation sequencing in immunogenetics and molecular oncology
B Grumbt, SH Eck, T Hinrichsen, K Hirv - Transfusion Medicine and …, 2013 - karger.com
With the introduction of the next generation sequencing (NGS) technologies, remarkable
new diagnostic applications have been established in daily routine. Implementation of NGS …
new diagnostic applications have been established in daily routine. Implementation of NGS …
Impact of next generation sequencing results on clinical management in patients with hematological disorders
BJ Patel, SV Barot, Y Xie, JR Cook… - Leukemia & …, 2021 - Taylor & Francis
Application of next generation sequencing (NGS) has shed light on the molecular
heterogeneity of hematological malignancies. NGS panels targeting recurrent mutations …
heterogeneity of hematological malignancies. NGS panels targeting recurrent mutations …